Description
রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন
Indications: PATADIN MAX (Olopatadine) is indicated for the treatment of ocular itching and redness associated with allergic conjunctivitis, including seasonal allergic conjunctivitis, vernal keratoconjunctivitis, vernal keratitis, blepharitis, blepharoconjunctivitis, and giant papillary conjunctivitis. It helps relieve symptoms like itchy, watery, red, and swollen eyes and/or eyelids.
Pharmacology: Olopatadine is a relatively selective histamine H1-receptor antagonist and a mast cell stabilizer. It works by inhibiting the release of histamine from mast cells, thereby reducing the immediate hypersensitivity reaction in vivo and in vitro. It also inhibits histamine-induced effects on human conjunctival epithelial cells. Olopatadine is devoid of effects on alpha-adrenergic, dopamine, and muscarinic type 1 and 2 receptors. Following topical ocular administration, olopatadine has low systemic exposure.
Dosage:
- 0.1% Sterile Eye Drops: One drop in each affected eye two times per day at an interval of 6 to 8 hours.
- 0.2% Sterile Eye Drops (Patadin Max): One drop in the affected eye once a day.
- 0.7% Sterile Eye Drops: One drop in each affected eye once a day.
- For children, consult a doctor regarding dosage as safety and efficacy have not been established in all age groups (e.g., below 2 or 3 years depending on concentration).
Administration:
- Wash your hands thoroughly before use.
- Tilt your head back and gently pull down the lower eyelid to create a small pocket.
- Hold the dropper bottle upside down, directly over your eye.
- Gently squeeze the bottle to dispense one drop into the created pocket.
- Do not let the dropper tip touch your eye, eyelid, or any other surface to avoid contamination.
- Close your eye gently for 1-2 minutes without blinking to allow the medication to spread.
- If you are using other eye drops, wait at least 5 minutes between each application.
- Replace the cap tightly after use.
Interaction: Concomitant use with CNS depressants may result in additive CNS depression. No other significant drug interactions are known with topical ocular olopatadine.
Contraindications: PATADIN MAX ophthalmic solution is contraindicated in persons with a known hypersensitivity to Olopatadine Hydrochloride or any component of the formulation.
Side Effects: Commonly reported side effects (incidence of 7% or less) include:
- Headache
- Asthenia (weakness or lack of energy)
- Blurred vision
- Burning or stinging sensation in the eye
- Cold syndrome
- Dry eye
- Foreign body sensation
- Hyperemia (redness of the eye)
- Hypersensitivity reactions
- Keratitis (corneal inflammation)
- Lid edema (eyelid swelling)
- Nausea
- Pharyngitis (sore throat)
- Pruritus (itching)
- Rhinitis (runny nose)
- Sinusitis
- Taste perversion (altered taste sensation)
Less common side effects may include eye pain, eye irritation, abnormal eye sensation, increased tear production, light sensitivity, and crusting of the eyelid margin. If any serious or persistent side effects occur, consult your doctor.
Pregnancy & Lactation:Pregnancy: There are no adequate and well-controlled studies in pregnant women. Animal studies are not always predictive of human responses. This drug should be used in pregnant women only if the potential benefit to the mother justifies the potential risk to the fetus.Lactation: It is not known whether topical ocular administration of olopatadine could result in sufficient systemic absorption to produce detectable quantities in human breast milk. However, caution should be exercised when administering PATADIN MAX ophthalmic solution to a nursing mother.
Precautions & Warnings:
- For topical ocular use only. Not for injection or oral use.
- Do not use PATADIN MAX ophthalmic solution to treat irritation related to contact lenses.
- Patients who wear soft contact lenses should be instructed to remove them before instilling PATADIN MAX ophthalmic solution and wait at least ten minutes before reinserting their lenses. The preservative (benzalkonium chloride) in the drops can be absorbed by soft contact lenses and may cause discoloration or irritation.
- If your eye is red, you should not wear contact lenses.
- To prevent contamination, do not touch the dropper tip to any surface, including the eye or eyelids.
- If symptoms do not improve or worsen, consult your doctor.
- Temporary blurred vision may occur after instillation; avoid driving or operating machinery until vision clears.
Therapeutic Class: Ophthalmic Non-Steroid medications / Ophthalmic Anti-allergic / Mast Cell Stabilizer and H1-Antagonist.
Storage Conditions: Store below 30°C in a cool, dry, and light-protected place. Keep out of reach of children. Do not use after 30 days of first opening the bottle.
.jpg)
Change Language